💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

Health-care Stocks Lead TSX Higher at Outset

Published 2024-07-30, 06:39 a/m
© Reuters Health-care Stocks Lead TSX Higher at Outset
US500
-
MSFT
-
DOW
-
MRK
-
SBUX
-
PFE
-
AMD
-
GSPTSE
-
BCE
-
CNQ
-
CP
-
LUN
-
ENB
-
CRWD
-

Baystreet.ca - Equities rose on Tuesday, led by gains in health-care shares, while investors await a raft of earnings and U.S. Federal Reserve's rate decision to gauge the outlook for global monetary policy.

The TSX Composite Index rebounded 105.7 points to open Tuesday at 22,885.27.

The Canadian dollar nicked ahead 0.01 cents at 72.18 cents U.S.

Some major Canadian companies, such as BCE (TSX:BCE), Canadian Natural Resources (TSX:CNQ), Canadian Pacific Kansas City (TSX:CP) and Enbridge (TSX:ENB), are due to report quarterly earnings this week.

BCE shares gained six cents to $46.16, while those for Natural Resources copped 16 cents to $47.40. CP shares rumbled ahead 40 cents to $114.46, while shares in Enbridge took on 20 cents to $51.04.

Global miner BHP Group and Canada-listed Lundin Mining (TSX:LUN) will jointly take over developer Filo Corp for $4.5 billion, as they move to progress the South American projects. Lundin shares captured 12 cents to $14.36.

ON BAYSTREET

The TSX Venture Exchange slumped 0.44 points early Tuesday to 573.93.

All but one of the 12 TSX subgroups were positive, with health-care sprinting 3.4%, while consumer staples and industrials each registered higher 0.6%.

Only real-estate missed the party, and not by much, losing but 0.01%.

ON WALLSTREET

The S&P 500 rose on Tuesday as investors digested key corporate earnings and looked to the Federal Reserve’s policy meeting.

The Dow Jones Industrials grabbed 156.04 points to 40,695.97.

The much-broader index poked up 0.84 points to 5,464.22.

CrowdStrike (NASDAQ:CRWD) shares fell more than 6% after media reports that Delta Air Lines (NYSE:DAL) hired attorney David Boies to seek damages from CrowdStrike and Microsoft (NASDAQ:MSFT) after an outage this month led to thousands of flight cancellations.

Merck shares fell more than 3% as weaker-than-expected guidance for the full year overshadowed a strong second-quarter report. Pfizer (NYSE:PFE), meanwhile, climbed 0.5% on stronger-than-anticipated earnings and revenue. The company also raised its full-year top and bottom line guidance.

Investors will also watch closely for numbers from Microsoft, Advanced Micro Devices (NASDAQ:AMD) and Starbucks (NASDAQ:SBUX) after the closing bell.

The earnings season has been a solid one thus far. Of the more than 230 S&P 500 names that have reported, about 80% have beaten earnings expectations,

Prices for the 10-year Treasury stayed put, with yields not budging from Monday’s 4.17%.

Oil prices decreased 80 cents at $75.01 U.S. a barrel.

Gold prices shone brighter $12.70 to $2,390.50

This content was originally published on Baystreet.ca

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.